4553 — Towa Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Towa Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	22,915	32,830	24,257	29,650	45,471
Net Total Accounts Receivable
Net Total Receivables	45,784	50,748	54,392	71,657	71,631
Total Inventory
Total Other Current Assets
Total Current Assets	137,290	166,864	182,990	217,718	247,306
Net Property, Plant And Equipment	85,898	99,873	127,004	153,642	168,423
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	245,668	332,097	371,347	430,653	470,823
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	51,516	115,073	78,529	80,118	87,939
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	129,069	199,928	234,453	274,760	299,198
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	116,599	132,169	136,894	155,893	171,625
Total Liabilities & Shareholders' Equity	245,668	332,097	371,347	430,653	470,823
Total Common Shares Outstanding